cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Axsome Therapeutics Inc
18 own
17 watching
Current Price
$68.7
$-5.59
(-7.52%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,983.35M
52-Week High
52-Week High
82
52-Week Low
52-Week Low
20.63
Average Volume
Average Volume
1.91M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,983.35M
icon52-Week High82
icon52-Week Low20.63
iconAverage Volume1.91M
iconDividend Yield--
iconP/E Ratio--
What does the Axsome Therapeutics Inc do?
Developing an oral formulation of an existing therapy for pain and osteoarthritis.
Read More
How much money does Axsome Therapeutics Inc make?
News & Events about Axsome Therapeutics Inc.
Stock Options Channel
1month ago
Investors in Axsome Therapeutics Inc (AXSM) saw new options begin trading today, for the February 2023 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 70 days until expiration the newly trading contracts represent a ...
InvestorPlace
2 months ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Recent reports claim that Tesla (TSLA) is planning to revamp the Model 3 under the secret "Highland" project and we have the details! The post 10 Things to Know as Tesla Revamps Model 3 With Project Highland appeared first on ...
PR Newswire
2 months ago
Thinking about trading options or stock in Axsome Therapeutics, Sarepta Therapeutics, Las Vegas Sands, Apple, or Microsoft? Thinking about trading options or stock in Axsome Therapeutics, Sarepta Therapeutics, Las Vegas Sands, Apple, or Microsoft? PR Newswire NEW YORK, Nov. 28, 2022 NEW YORK, Nov...
Globe Newswire
2 months ago
NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsomes Chief Executive Officer, will ...
Globe Newswire
3 months ago
Axsome to host conference call and webcast on Monday, November 7, 2022 at 8:00 AM Eastern Time NEW YORK, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS...
Frequently Asked Questions
Frequently Asked Questions
What is Axsome Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Axsome Therapeutics Inc shares?
plus_minus_icon
How can I buy Axsome Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Axsome Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Axsome Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Axsome Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Axsome Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Axsome Therapeutics Inc?
plus_minus_icon
What percentage is Axsome Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Axsome Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$68.7
$-5.59
(-7.52%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00